Celularity Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares
Celularity Inc. (CELU) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares of 2.61 million shares for the 3-month period ending 2021-06-30, per its 10-K filed 2023-03-31.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares · last filed 2023-03-31
- Celularity Inc. share-based compensation arrangement by share-based payment award, options, vested, number of shares for the quarter ending 2021-06-30 was 2.61M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares 1 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares 3 month |
|---|---|---|
| 2021-06-30 | 2.61M shares 10-K · filed 2023-03-31 | |
| 2021-03-31 | 269.01K shares 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |